| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Moxifloxacin | FAERS: 3 | US FAERS | |
| 2 | Venlafaxine Hydrochloride | FAERS: 2 | US FAERS | |
| 3 | 4-Aminopyridine | FAERS: 1 | US FAERS | |
| 4 | Aspirin | FAERS: 1 | US FAERS | |
| 5 | Ciprofloxacin | FAERS: 1 | US FAERS | |
| 6 | Epinephrine | FAERS: 1 | US FAERS | |
| 7 | Ibuprofen | FAERS: 1 | US FAERS | |
| 8 | Quetiapine Fumarate | FAERS: 1 | US FAERS | |
| 9 | Rivastigmine | FAERS: 1 | US FAERS | |
| 10 | Thyroxine | FAERS: 1 | US FAERS | |
| 11 | Valacyclovir | FAERS: 1 | US FAERS | |
| 12 | Varenicline | FAERS: 1 | US FAERS | |
| 13 | beyaz | FAERS: 1 | US FAERS | |
| 14 | niraparib | FAERS: 1 | US FAERS | |
| 15 | pimavanserin | FAERS: 1 | US FAERS | |
| 16 | regorafenib | FAERS: 1 | US FAERS | |
| 17 | Prazepam | OFFSIDES | ||
| 18 | riociguat | Canada Vigilance: 1 | Canada Vigilance |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120242
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.